The National Board of Medicines has given prior notice to the importation and sale of these tests. It is a very popular option, in addition to the PCR-RT exams.
The pharmaceutical companies are involved in the import and commercialization of antigen tests to detect COVID-19, which will be known before the National Medicines Agency (DNM), dependent on the Ministry of Health.
The DNM explained in a communication, published in its social speeches, that it carried out “the corresponding technical evaluations” for this type of examinations.
Related topic: Gobierno plana accept antigen tests to enter airspace in El Salvador, what does it mean?
The antigen tests, also called rapid reactions, require a sample via nasopharyngeal hypothalamus. Luego, dicha muestra es colocada in a test, similar to a test of embarrassment, and according to the chemical reaction in dicha prueba, the person knows if in his body there are residues of antibodies that his organism generates before the presence of the virus.
Without embarrassment, this test indicates that the virus is permanently active, or not, in person. For a real-time result, a PCR-RT test is always required.
The price of these antigen samples has not been determined by the DNM, nor do the brands or manufacturers comply with the quality standards. Since a probe has been initiated by El Diario de Hoy, and it is clear that these tests do not comply with this sanitary authorization, there are various private laboratories offering this service, which round between 70 and 100 dollars.
The rapid tests at great cost are a great help for first-line personnel and other workers who require a test indicate that their negatives, as of August 2020, the epidemiologist Ricardo Lara. Photo EDH / archive
In the case of Costa Rica, there is a cost of $ 60, and $ 40 in Guatemala, as well as information and laboratory internet that they offer.
The sale of this type of test is that it takes between 20 and 45 minutes to complete the test.
Rapid trials have an option for citizens of various countries at the global level during months, as in the United States, Mexico and Guatemala, to mention certain cases.
In El Salvador, inspectors from the DNM are retrieving the market samples of this type that will be found in their pharmaceutical sales by November 26, 2020.
The post office changed, until August 2020, the recent appointment as National Director of Medicines, Noé Geovanni García, declares that this institution did not authorize this type of rapid trial by COVID-19, because the same “no guarantee” that the results are reliable ”.
As a precedent, according to a statement from the Pan-American Organization of Health (OPS), this unit distributes tens of thousands of fast samples of antigens to COVID-19 and has its efficacy in four Latin American countries: 000 (40,000) (El 80,000) Honduras (40,000) and Suriname (30,000).